Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 1/20 | 0.44 |
| ▸ | FNTB | P49356 | 1/20 | 0.44 |
| ▸ | GPR119 | Q8TDV5 | 12/20 | 0.44 |
| ▸ | IDO1 | P14902 | 1/20 | 0.42 |
| ▸ | TDO2 | P48775 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.41 |
| ▸ | FEN1 | P39748 | 1/20 | 0.41 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14285782 | 0.91 | FNTA (0.43) | FNTAFNTBGPR119IDO1TDO2 | |
| SCHEMBL16688920 | 0.85 | GPR119 (0.46) | FNTAFNTBGPR119IDO1TDO2 | |
| SCHEMBL16520051 | 0.83 | SSTR4 (0.52) | FNTAFNTBGPR119IDO1TDO2 | |
| SCHEMBL26590176 | 0.81 | IDO1 (0.39) | FNTAFNTBGPR119IDO1TDO2 | |
| SCHEMBL29968865 | 0.81 | IDO1 (0.39) | FNTAFNTBGPR119IDO1TDO2 | |
| SCHEMBL386491 | 0.80 | GPR119 (0.50) | FNTAFNTBGPR119IDO1TDO2 | |
| SCHEMBL17837669 | 0.78 | GPR119 (0.48) | FNTAFNTBGPR119IDO1TDO2 | |
| SCHEMBL29960962 | 0.78 | GPR119 (0.50) | FNTAFNTBGPR119IDO1TDO2 | |
| SCHEMBL28510099 | 0.78 | GPR119 (0.50) | FNTAFNTBGPR119IDO1TDO2 | |
| SCHEMBL15088038 | 0.77 | IDO1 (0.47) | FNTAFNTBGPR119IDO1TDO2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080103123-A1 | New compounds | BIOVITRUM (SE) | 2008-05-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080103123-A1 | New compounds | GPR119, GPR139, GPR180 | FNTA 2175/4885FNTB 2886/4885GPR119 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.